Double-Blind, Randomized Controlled Trial Comparing Platlet-Rich Plasma - 46

AAOS 2019 Annual Meeting - Las Vegas, NV

Matthew Kraeutler, M.D., during A Double-Blind, Randomized Controlled Trial Comparing Platelet-Rich Plasma versus Hyaluronic Acid for Early Osteoarthritis of the Hip Joint

1 / 20

Matthew Kraeutler, M.D., during A Double-Blind, Randomized Controlled Trial Comparing Platelet-Rich Plasma versus Hyaluronic Acid for Early Osteoarthritis of the Hip Joint

Las Vegas, NV - AAOS 2019 - Matthew Kraeutler, M.D., during A Double-Blind, Randomized Controlled Trial Comparing Platelet-Rich Plasma versus Hyaluronic Acid for Early Osteoarthritis of the Hip Joint at the American Academy of Orthopedic Surgeons (AAOS) 2019 Annual meeting at the Las Vegas Sands Expo Center here today, Wednesday March 13, 2019. With over 30,000 attendees, the conference is the preeminent meeting on musculoskeletal education to orthopaedic surgeons and allied health professionals in the world. Photo by © AAOS/Phil McCarten 2019 - 46-A Double-Blind, Randomized Controlled Trial Comparing Platelet-Rich Plasma versus Hyaluronic Acid for Early Osteoarthritis of the Hip Joint

46A DoubleBlind Randomized Controlled Trial Comparing PlateletRich Plasma versus Hyaluronic Acid for Early Osteoarthritis of the Hip Joint